Abstract
Central disorders of hypersomnolence are characterized by daily periods of irrepressible need to sleep or daytime lapses into sleep, as defined in the current version of the International Criteria of Sleep Disorders. Thus, the unifying symptom is excessive daytime sleepiness which is not caused by any other sleep-wake disorder. Relevant disorders including narcolepsy type 1 and 2, idiopathic hypersomnia, Kleine-Levin syndrome, and insufficient sleep syndrome will be discussed. Other central disorders of hypersomnolence include hypersomnias due to medical or psychiatric disorders or because of medication or substance use.
In sleep-related movement disorders, the cardinal symptom consists of simple, often stereotyped movements occurring during sleep. The most frequent disorder in this category of sleep-wake disorders is restless legs syndrome, which is often associated with period limb movements during sleep.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ali M, Auger RR, Slocumb NL et al (2009) Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med 5(6):562–568
Allen RP, Picchietti DL, Garcia-Borreguero D et al (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Med 15(8):860–873
Allen RP, Picchietti DL, Auerbach M et al (2018) Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 41:27–44
American Academy of Sleep Medicine (AASM) (2014) The International Classification of Sleep Disorders – third edition (ICSD-3). American Academy of Sleep Medicine, Darien
Antelmi E, Provini F (2015) Propriospinal myoclonus: the spectrum of clinical and neurophysiological phenotypes. Sleep Med Rev 22:54–63
Arnulf I (2015) Kleine-Levin syndrome. Sleep Med Clin 10:151–161
Arnulf I, Lin L, Gadoth N et al (2008) Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 63:482–493
Bassetti CL, Bornatico F, Fuhr P, Schwander J, Kallweit U, Mathis J, Swiss RLS study group (2011) Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial. Swiss Med Wkly w13274:141
Baumann CR, Mignot E, Lammers GJ et al (2014) Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep 37(6):1035–1042
Bayard M, Bailey B, Acharya D et al (2011) F. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 24(4):422–428
Cippà MA, Baumann CR, Siccoli MM, Bassetti CL, Poryazova R, Werth E (2013) Actigraphic assessment of periodic leg movements in patients with restless legs syndrome. J Sleep Res 22(5):589–592
Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ (2011) Profile of altered brain iron acquisition in restless legs syndrome. Brain 134(Pt 4):959–968
Cvetkovic-Lopes V, Bayer L, Dorsaz S et al (2010) Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 120(3):713–719
Earley CJ, Connor J, Garcia-Borreguero D et al (2014) Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease). Sleep Med 15(11):1288–1301
Garcia-Borreguero D, Silber MH, Winkelman JW et al (2016) Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21:1–11
Haba-Rubio J, Marti-Soler H, Marques-Vidal P et al (2016) Prevalence and determinants of periodic limb movements in the general population. Ann Neurol 79(3):464–474
Hallmayer J, Faraco J, Lin L et al (2009) Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41(6):708–711
Hening WA, Allen RP, Washburn M, Lesage SR, Earley CJ (2009) The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”). Sleep Med 10(9):976–981
Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Koskimies S, Guilleminault C (1994) The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol 35(6):709–716
Iber C, Ancoli-Israel S, Chesson A et al (2007) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, Westchester
John J, Thannickal TC, McGregor R et al (2013) Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol 74(6):786–793
Kecklund G, Axelsson J (2016) Health consequences of shift work and insufficient sleep. BMJ 355:i5210
Koo BB (2015) Restless leg syndrome across the globe: epidemiology of the restless legs syndrome/Willis-Ekbom disease. Sleep Med Clin 10(3):189–205
Kornum BR, Knudsen S, Ollila HM, Pizza F, Jennum PJ, Dauvilliers Y, Overeem S (2017) Narcolepsy. Nat Rev Dis Primers 3:16100
Kretzschmar U, Werth E, Sturzenegger C et al (2016) Which diagnostic findings in disorders with excessive daytime sleepiness are really helpful? A retrospective study. J Sleep Res 25(3):307–313
Lavault S, Golmard J, Groos E et al (2015) Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol 77:529–540
Lee YJ, Park J, Kim S, Cho SJ, Kim SJ (2015) Academic performance among adolescents with behaviorally induced insufficient sleep syndrome. J Clin Sleep Med 11(1):61–68
Maric A, Montvai E, Werth E et al (2017) Insufficient sleep: enhanced risk-seeking relates to low local sleep intensity. Ann Neurol 82(3):409–418
Marti I, Valko PO, Khatami R, Bassetti CL, Baumann CR (2009) Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med 10:1146–1150
Mayer G, Benes H, Young P et al (2015) Modafinil in the treatment of idiopathic hypersomnia without long sleep time-a randomized, double-blind, placebo-controlled study. J Sleep Res 24(1):74–81
Mignot E, Lin L, Rogers W et al (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68(3):686–699
Morita Y, Sasai-Sakuma T, Asaoka S, Inoue Y (2015) Prevalence and correlates of insufficient sleep syndrome in Japanese young adults: a web-based cross-sectional study. J Clin Sleep Med 11:1163–1169
Neikrug AB, Crawford MR, Ong JC (2017) Behavioral sleep medicine services for hypersomnia disorders: a survey study. Behav Sleep Med 15(2):158–171
Ohayon MM, Reynolds CF 3rd, Dauvilliers Y (2013) Excessive sleep duration and quality of life. Ann Neurol 73(6):785–794
Ozaki A, Inoue Y, Hayashida K et al (2012) Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population. Sleep Med 13(2):200–206
Papacostas SS, Hadjivasilis V (2000) The Kleine-Levin syndrome. Report of a case and review of the literature. Eur Psychiatry 15:231–235
Peyron C, Faraco J, Rogers W et al (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6(9):991–997
Philip P, Chaufton C, Taillard J et al (2014) Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Sleep 37(3):483–487
Pizza F, Antelmi E, Vandi S et al (2018) The distinguishing motor features of cataplexy: a study from video recorded attacks. Sleep [Epub ahead of print]
Ruoff C, Pizza F, Trotti LM et al (2018) The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study. J Clin Sleep Med 14(1):65–74
Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257–1263
Scammell TE (2015) Narcolepsy. N Engl J Med 373(27):2654–2662
Stefansson H, Rye DB, Hicks A et al (2007) A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357(7):639–647
Szakacs Z, Dauvilliers Y, Mikhaylov V et al (2017) Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16(3):200–207
Taddei RN, Werth E, Poryazova R, Baumann CR, Valko PO (2016) Diagnostic delay in narcolepsy type 1: combining the patients’ and the doctors’ perspectives. J Sleep Res 25(6):709–715
Thannickal TC, Moore RY, Nienhuis R et al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3):469–474
Trotti LM (2017) Idiopathic hypersomnia. Sleep Med Clin 12(3):331–344
Trotti LM, Staab BA, Rye DB (2013) Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med 9(8):789–795
Trotti LM, Saini P, Bliwise DL et al (2015) Clarithromycin in gamma-aminobutyric acid-related hypersomnolence: a randomized, crossover trial. Ann Neurol 78(3):454–465
Valko PO, Gavrilov YV, Yamamoto M et al (2013) Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol 74(6):794–804
Van Dongen HP, Maislin G, Mullington JM, Dinges DF (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26(2):117–126
Winkelmann J, Schormair B, Lichtner P et al (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39(8):1000–1006
Winkelmann J, Czamara D, Schormair B et al (2011) Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 7(7):e1002171
Conflicts of Interest
Dr. Baumann reports no conflicts of interests in regard to this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Baumann, C.R. (2018). Clinical Sleep-Wake Disorders I: Focus on Hypersomnias and Movement Disorders During Sleep. In: Landolt, HP., Dijk, DJ. (eds) Sleep-Wake Neurobiology and Pharmacology . Handbook of Experimental Pharmacology, vol 253. Springer, Cham. https://doi.org/10.1007/164_2018_126
Download citation
DOI: https://doi.org/10.1007/164_2018_126
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11270-7
Online ISBN: 978-3-030-11272-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)